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ABSTRACT: The newly discovered macrolactone mucorolactone, along with 8 known compounds, was isolated from an ethyl 
acetate extract of the insect-born fungus Mucor sp. All structures were elucidated using 1D and 2D NMR and MS spectroscopic 
experiments. Relative and absolute configurations of the original skeleton of mucorolactone was deduced from NOESY experi-
ment, from the 
13
C NMR chemical shifts calculation based on the DP4 probability method, and from the comparison of experi-
mental and calculated electronic circular dichroism spectra. 
Natural products are a historically successful option in the 
drug discovery and development process. They have an indis-
pensable role to play, continuing to provide for and influence 
the search and development of current therapeutic drugs in 
spite of the reduced level of natural products based drug dis-
covery programs.
1
 The recent decade has seen a growing 
recognition that natural products isolated from plants and 
animals may sometimes be the metabolic products of co-living 
microbes.
2
 This fact leads researchers to the exploration of 
underrated ecological niches to identify novel chemical enti-
ties. Consequently, natural products regulating insect–microbe 
interactions have emerged as a promising resource for drug 
discovery.
3,4
 These microorganisms, either mutualists or path-
ogens, generate a number of secondary metabolites involved 
in the mechanisms of defense, protection, or virulence.
5,6 
Among them, entomopathogenic microorganisms are expected 
to produce insecticides and antimicrobial compounds during 
the process of infection and proliferation.
7
 In our work, we 
undertook the exploration of secondary metabolites of the 
fungus Mucor sp. isolated from the cuticle of an alive, yet 
infected, unidentified wasp (Vespidae) collected in French 
Guiana. 
 
Figure 1. The structure of mucorolactone (1). 
A fractionation was performed on the ethyl acetate extract 
of Mucor sp. SNB-VECD13A and a new compound 1 (Figure 
1) was isolated, along with known dehydroabietic acid,
8
 
cyclo(L-Pro-L-Phe),
9
 N-acetyltryptophane,
10
 daidzein,
11
 2-(4-
hydroxyphenyl)ethyl acetate,
12
 phenylacetic acid,
13
 ergosterol-
  
2 
5α,8α-peroxide,
14
 and ergosta-5,7,22-trienol.
15
 Known com-
pounds were identified by the comparison of their analytical 
data with those from the literature, as described in the Sup-
porting Information. 
Table 1. 1H and 13C NMR Data of Compound 1a 
1 
no.  δH, mult (J in Hz) δC  
1 4.32, d (7.6) 106.1  
2 3.15, dd (9.4, 7.6) 75.5 
3 3.329, br t (9.3) 77.5 
4 3.51, br t (9.3) 70.6 
5 3.332, br dt (9.6, 2.0) 74.6 
6 a: 4.13, dd (11.7, 1.6) 63.2 
b: 4.44, dd (11.7, 2.5) 
7 5.33, br t (2.7) 76.0 
8 3.73, br q (2.5) 77.3 
9 ax: 2.04, dt (15.2, 3.8) 34.5 
eq: 2.12, br d (15.2) 
10 3.95, br q (2.1) 70.1 
11 1.71, m  38.6 
12 2.85, br d (10.1) 39.1 
13 6.08, br t (10.7) 131.1 
14 5.46, br td (11.2, 5.2) 130.8 
15 a: 1.76, m 27.6 
b: 2.43, m 
16 1.50, m 31.0 
17 a: 1.64, m 26.5 
 b: 1.84, m  
18 a: 2.27, ddd (13.8, 8.8, 5.2) 36.6 
b: 2.41, m  
19  175.6 
20  174.0 
21 a: 2.29, dt (15.0, 7.3) 
b: 2.33, dt (15.0, 7.3) 
35.6 
22 1.61, m 26.5 
23-34  1.21-1.35, m 23.8 to 33.3 
35/40 0.89/0.90, t (7.0) 14.6 
36 1.42, m 31.3 
37-39 1.21-1.35, m 23.8 to 33.3 
a Measured at 500 MHz for 1H and 125 MHz for 13C, in methanol-
d4 
Compound 1 was obtained as a yellow oil. It has the molec-
ular formula C40H70O10, as deduced from the HR-ESI
+
-MS 
molecular ion sodium adduct at m/z 733.4881 [M + Na]
+
 
(calcd for C40H70O10Na, 733.4879), corresponding to 6 degrees 
of unsaturation. The examination of the 
1
H, 
13
C, and HSQC 
spectra of 1 allowed the identification of two triplet methyls at 
δH 0.89 and 0.90 and thirteen methines [δH 6.08, 5.46, 5.33, 
4.44, 4.32, 4.13, 3.95, 3.73, 3.51, 3.34, 3.33, 3.15 and 2.85] 
among which two were olefinic protons (δH 6.08, H-13 and δH 
5.46, H-14). Several methylenes were identified under a broad 
signal at δH 1.30. The 
13
C NMR spectrum of 1 showed the 
presence of two quaternary carbons corresponding to ester 
groups at δC 175.7 and 174.0 and nine oxygenated carbons 
between δC 63.1 and 106.1 (Table 1). The presence of a 
pyranose moiety was confirmed by the sequence of 
1
H – 
1
H 
COSY cross-peaks for H-1/H-2/H-3/H-4/H-5 and H-6 along 
with HMBC correlation H-1 to C-5 (Figure 2). An additional 
sequence of 
1
H – 
1
H cross-peak H-7/H-8/H-9/H-10 and H-11 
along with HMBC correlations between H-8/C-9, H-10/C-8 
and C-12, H-11/C-12, and H-12/C-7 and C-10 allowed the 
determination of another six-membered ring linked to the 
pyranose moiety by C-8 as shown by the H-1/C-8 and H-8/C-1 
correlations (Figure 2). Note that the unusual C-11–C-12 bond 
is revealed by the H-11–H-12 COSY correlation, and the 
correlations H-11/C-12, H-10/C-12 and H-12/C-10 in HMBC. 
The
 1
H-
1
H COSY sequence signal from H-12 to H-18 estab-
lished a carbon side chain linked to C-12 and includes the two 
methines H-13 and H-14 in a cis double bond (J = 11.3 Hz, 
Figure 2). HMBC cross signals H-6/C-19 and H-18/C-19 
confirmed the C-6–O–C-19 linkage demonstrating the pres-
ence of a macrolactone. The correlation of H-7 with C-20 and 
1
H-
1
H coupling between H-11 and H-36 allowed us to attach 
an alkyl side chain in C-11 and a fatty acid chain in C-7. The 
relative length of both side chains could not be established by 
NMR due to extensive overlapping of the CH2 signals in 
1
H 
and 
13
C. In LC-ESI
-
-MS
2
, the fragmentation of the pseudo-
molecular ion yielded two characteristic fragments at m/z 
255.2323 ([C16H31O2]
-
) and 471.2584 ([M–C16H31O]
-
). These 
originate from the cleavage of the C-7–O and the O–C-20 
bonds, respectively (Scheme 1). In LC-ESI
+
-MS
2
, the 
[M+Na]
+
 adduct fragmented to give a daughter ion at m/z 
477.2457 ([M+Na-C16H32O2]
+
). All these findings are con-
sistent with the existence of palmitate esters on C-7 and a five-
carbon side chain in C-11.  
Figure 2. A) COSY (bold), and key HMBC (plain arrows) corre-
lations in compound 1; B) key NOE correlations in the glucose 
moiety (dashed arrows). Hydroxyl groups in positions 2-4 have 
not been represented for clarity; C) key NOE correlations in the 
cyclohexane ring (dashed arrows). 
The anomeric proton configuration was assigned based on 
H-1 chemical shift and on the coupling constant value of 7.6 
Hz between H-1 and H-2. This is consistent with a β–
configuration. Based on the same principle, the vicinal cou-
pling constant between the successive pyranose protons pro-
vided information about their relative configuration. Large J 
couplings observed within the sequence H-2 to H-5 confirmed 
the axial configuration of H-2, H-3, H-4 and H-5. These orien-
tations were confirmed by the NOESY spectrum where
 
corre-
lations were observed between the anomeric proton H-1 (δH 
4.32) and H-3 and/or H-5, and between H-2 and H-4. The 
  
3 
pyranose was therefore defined as a glucose moiety. The rela-
tive stereochemistry in the cyclohexane ring was determined 
as follows. First, H-8 and H-10 both have 3 small vicinal 
coupling constants (J ≈ 2.5 Hz and J ≈ 2.1 Hz, respectively). 
Since one of the H-9 protons is necessarily axial, then H-8 and 
H-10 must be equatorial. The axial H-9 proton at δ 2.04 could 
be identified due to the NOE correlation with H-11. H-12 has 
one large coupling with H-13 and two small couplings with H-
11 and H-7. Since H-11 is axial, then H-12 has to be equatori-
al. This was confirmed by the NOE correlation between H-11 
and H-12. Finally, the COSY experiment indicated that H-7 
was coupled with H-9eq (W-coupling) and should therefore be 
equatorial. This assumption was reinforced by the NOE cou-
pling between H-7 and H-13. 
Scheme 1. LC-MS
2
 Fragmentation of 1 (up: positive mode; 
down: negative mode) 
 
The only stereochemical information linking the glucose to 
the cyclohexane ring is an NOE correlation between H-1 and 
H-8. However, this was not enough to determine the relative 
configurations of these two moieties (Figure 3). A 
13
C NMR 
chemical shift calculation by the DP4 probability method was 
performed.
16
 Due to the flexibility of the compound, 
13
C NMR 
calculations have been performed on the conformers within 
1kcal.mol
-1
 using Gaussian 09W with the B3LYP method at 
the 6-311+G(d,p) level. The Boltzmann weighted chemical 
shifts have been compared to the experimental ones using an 
in house implementation of the Java source code available on 
the Goodman’s group page (http://www-
jmg.ch.cam.ac.uk/tools/nmr/DP4/). The diastereoisomer a was 
deduced to be correct with a 100% probability. 
The experimental electronic circular dichroism spectrum of 
1 was recorded in t-BuOMe. It shows a broad positive absorp-
tion band centered at 220 nm. The calculated ECD spectrum 
of the enantiomer in Figure 1 agreed well with the experi-
mental data (See supporting information), therefore supporting 
the absolute configuration in which the glucose moiety is D. 
The initial goal was to find new insecticides. Mucorolactone 
was tested on Aedes aegypti larvae and was not active. 
Figure 3. Both possible diastereoisomers of 1 (R = pentyl). 
In conclusion, this letter reports the first description of 
mucorolactone (1), a unique macrocyclic compound isolated 
from a fungus of the genus Mucor. Interestingly, the right side 
of compound 1, from the ester group in C-19 to the pentyl side 
chain (C-36–C-40), seems to be formed by cyclization (for-
mation of the C-11–C-12 bond) and oxidation of -linolenic 
acid to generate the functionalized cyclohexane ring. Bacteria 
from the Alicyclobacillus and Sulfobacillus genera are known 
to produce -cyclohexyl fatty acids,
17
 but simple 6-membered 
rings in the middle of a fatty acid chain are very rare in nature. 
One example is the isolation of rubrenoic acids A–C from the 
marine bacterium Alteromonas rubra.
18
 These compounds 
probably originate from the 7–12 cyclization of a C16 fatty 
acid, but the biosynthetic pathway leading to the formation of 
such compounds is not known. It will be interesting to further 
investigate the biosynthesis of mucorolactone, which can be 
obtained in large amounts from Mucor sp. SNB-VECD13A. 
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